The Medicines Patent Pool (MPP) announced that it has signed agreements with 35 companies to manufacture the generic version of Pfizer’s oral COVID-19 treatment nirmatrelvir,
The Medicines Patent Pool (MPP) announced that it has signed agreements with 35 companies to manufacture the generic version of Pfizer’s oral COVID-19 treatment nirmatrelvir,
For more than a decade prior to the start of the war in Ukraine, scientific research collaborations between Russia and U.S. and EU-member nations were declining.
From the drawing board to the marketplace, a broad range of imaginative new inventions are reaching people faster and wider. Amazingly, many of TIME magazine’s best inventions
TikTok, the Chinese social media giant, is the world’s fastest growing brand, up 215% over 2021, according to BrandFinance, a firm that rates the Global
Non-resident patent applicants accounted for 90% of the patent applications received by the IP office of Australia in 2020, but only 10% of the applications received
A bastion of business coverage of large corporations since the 1920s, Fortune Magazine, lambasted BigTech companies because they “acquire and kill competitors and copy other
In the latest episode of ‘Understanding IP Maters,’ the podcast that looks at the IP stories of creators who became successful entrepreneurs, movie producer and
Frederick Shelton IV, arguably the most prolific and financially successful inventors ever, is a Johnson & Johnson medical device innovator unknown to pretty much everyone
In the decade since the adoption of the America Invents Act (AIA) patent licensing has become more arduous for many technology companies and independent inventors.
IP CloseUp celebrated its Tenth Anniversary in 2021, with viewership up 44% since 2018. Annual increases since 2018 were 7%, 11 % and 21%, respectively. The 2021
With the backing of leading private equity funds and record labels, celebrity singer-song writers such as Bob Dylan, Prince and Neil Young, are cashing in on strong long-term demand
Researchers’ unprecedented rapid response to the Covid-19 pandemic and that of the bio-pharmaceutical companies – which included sharing proprietary technology with many dozens of partners